Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps

Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps

Dec 11, 2019

Source URL: https://prod1.novartis.com/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps-0

List of links present in page
  1. https://prod1.novartis.com/us-en/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-treatment-nasal-polyps-0